BST
WST icon

Bath Savings Trust’s West Pharmaceutical WST Stock Holding History

Bath Savings Trust’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,125
Closed -$252K – 167
2025
Q1 		$252K Sell
1,125
-185
-14% -$51K 0.03% 150
2024
Q4 		$429K Sell
1,310
-155
-11% -$48.8K 0.04% 126
2024
Q3 		$440K Sell
1,465
-369
-20% -$113K 0.04% 127
2024
Q2 		$604K Sell
1,834
-152
-8% -$53.7K 0.06% 114
2024
Q1 		$786K Sell
1,986
-15
-0.7% -$5.55K 0.08% 102
2023
Q4 		$705K Hold
2,001
– – 0.08% 108
2023
Q3 		$751K Sell
2,001
-62
-3% -$24K 0.09% 102
2023
Q2 		$789K Sell
2,063
-33
-2% -$11.8K 0.09% 101
2023
Q1 		$726K Buy
2,096
+42
+2% +$12.3K 0.09% 103
2022
Q4 		$484K Buy
2,054
+1,225
+148% +$290K 0.06% 118
2022
Q3 		$204K Buy
+829
New +$253K 0.03% 146

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Bath Savings Trust's WST Position: Q2 2025 in Review

Bath Savings Trust sold out of West Pharmaceutical (WST) in Q2 2025, closing a stake of 1,125 shares — an estimated $252K sold.

Bath Savings Trust first reported a position in WST in Q3 2022 and held it in 11 quarters. The position peaked at $789K in Q2 2023. 730 funds tracked by Wall St. Rank hold WST as of Q2 2025.

  • Bath Savings Trust reported no remaining West Pharmaceutical position as of Q2 2025 after selling out during the quarter.
  • Bath Savings Trust sold 1,125 West Pharmaceutical shares in Q2 2025, an estimated $252K.
  • Bath Savings Trust first reported a position in West Pharmaceutical in Q3 2022 and held it in 11 quarters.
  • Bath Savings Trust's West Pharmaceutical position peaked at $789K in Q2 2023.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2025.

Based on Bath Savings Trust's 13F filing for Q2 2025, filed 10 Jul 2025.